Instrumentation Laboratory

Device Transactions Financing by device companies in the first quarter of 2017 totaled $2.3 billion, slightly lower than Q4 2016's $2.4 billion. Notably, early-stage venture capital fundraising made u

The clinical community needs in vitro diagnostics that can help guide treatment using a broader spectrum of anti-coagulation drugs – but such products won’t make it to the US market without the swif

Sysmex's break with US distribution partner Roche frees it to reap the rewards of building its own brand. It's got a stellar reputation, but the tough market doesn't leave much room for error. By Wend

DPC has successfully carved out a niche in immunoassay systems, but has it gone as far as it can on its own? by Wendy Diller Diagnostic Products Corp. is located down the road from the Los Angeles